Please complete the CAPTCHA to continue
@rutgers.edu
✓
3 phones found area 416 and 570
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
Tim Lee, Ph.D. is listed as Chief Scientific Officer Prollenium Medical Technologies, Adjunct Prof, U of Toronto at Class III Sterile Medical Device Biopharm, based in Canada, Canada, Canada. AeroLeads shows a work email signal at rutgers.edu, phone signal with area code 416, 570, and a matched LinkedIn profile for Tim Lee, Ph.D..
Tim Lee, Ph.D. previously worked as Chief Scientist/ Head of Research & Development at Class Iii Sterile Medical Device Biopharm and Director R&D at Class Iii Sterile Medical Device Biopharm. Tim Lee, Ph.D. holds Phd, Biochemical Engineering from Ucl.
This section adds company-level context without repeating Tim Lee, Ph.D.'s masked contact details.
AeroLeads found 1 current-domain work email signal for Tim Lee, Ph.D.. Compare company email patterns before reaching out.
Results-driven and innovative team leader with 15 plus years of biopharmaceutical experience. Proven track record in management of multi-disciplinary teams in product development and process transfer to manufacturing. Experience in achieving aggressive targets and timelines and productivity optimization. Analytical ability in providing insight from complex scientific data. Resourceful in achieving corporate goals through team leadership and crisis management.Specialties: • Product development to launch (Bulk, Formulate, Fill, Pack)• Strategic team leadership• GMP clinical manufacturing • Change management• Process scale-up & validation by QbD
Listed skills include Six Sigma, Lean Manufacturing, Performance, Cgmp, and 30 others.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
Toronto, Canada Area
- Regulatory approval of Class III Sterile Medical Devices Pre-Market Applications (PMA)- Defend Quality Management System for Health Canada, EU, Brazil, USA, Australia Audits- Instrumental in MDSAP Audit
Toronto, Ontario
-Managing research and development of dermal filler, Platelet Rich Plasma and osteoarthritis medical devices globally- Prepare and review clinical study design, progress and final reports for internal and external studies- Monitor patent and scientific literature and review competitor technology developments- Administer research budgets (plan budgets.
Mississauga Campus
-Masters in Biotechnology and Corporations (MBioTech Program)- Biopharmaceutical Manufacturing- cGMP compliance, sterility assurance, ICH guidelines on pharmaceutical development, risk management and Quality systems- Mergers and Acquisitions, IPO basics and VC
New Jersey/ Toronto
- Bio-Pharmaceutical Manufacturing- GxP compliance and ICH guidelines- Risk Management- Quality by Design- Biosimilarity and Comparability- Good Documentation- Audits, Inspections and Root Cause Analysis
Irvine California
- Leading upstream and downstream in the manufacturing of biologics and small molecules expressed in bacteria and mammalian cells- Late phase clinical manufacturing (Phase II/III) and IND submission- Managed a BSL3 facility for the development and production of Clostridium Botulinum- Member of the "Integrated Preclinical/Clinical AIDS Vaccine Development".
Greater Boston Area
Providing business proposals outlining development and manufacturing strategies for new opportunities within biopharma using scientific and technical know-hows to meet the customer's needsExpertise:Process Development & ManufacturingQuality Assurance and Quality ControlBiodefense/Pandemic ResponseDrug Delivery DevicesLee, Timothy. 2016. Parenterals and.
- Managed approximately 40 operators and managers to improve safety, quality and supply of products- Efficiency enhancements through design of daily management systems resulting in non-conformation reduction, increase safety and improved scheduling and production efficiencies
ORAL PRESENTATIONS Lee, Timothy. 2012. Challenges and Solutions to Downstream Bioprocessing Operations. World Congress Vaccine, Washington D.C.Lee, Timothy. 2011. Revolutionizing upstream and downstream process development. Bioprocessing Summit. Frankfurt, Germany.Lee. Timothy. 2010. Challenges and solutions to downstream bioprocessing operations for the.
Toronto
Generated $21M in annual operational cost savings through design and implementation ofprocess metric initiatives emphasizing continuous improvement* Executed cross-training plan for manufacturing staff members to improve operationalcompetency within department* Explored and designed ``Kaizen`` initiatives to control inventory of raw materials through 5S*.
Led multi-disciplinary staff and international process transfer from bench to 1000 Litremanufacturing scale* Generated 50% productivity increase and $2.3M annual operational cost savings* Managed cross-functional teams (manufacturing, Mtech, RA, QA, QC, purchasing, finance) andaccelerated project delivery to produce Phase II/III material in aggressive 2.
Designed and validated robust recovery processes by QbD resulting in increase in productivity(1 million doses), safety (10-fold reduction in LAL concentrations) and cost savings (eliminationof additional column purification step)
Constructed platform methodology for the recovery of soluble, inclusion body, membrane andextracellular proteins leading to reduction of process development time by 6 months tomanufacturing
Cloning Hepatitis B constructs and studying their effect in therapeutic experiments
Activities and Societies: Teaching Assistant in industrial bio-processing within the pilot plant at University of London
Activities and Societies: Critical Thinking & Innovation, Business Management Strategies, Management Communications Skills, Taking Control.
Quick answers generated from the profile data available on this page.
Tim Lee, Ph.D. works for Class III Sterile Medical Device Biopharm.
Tim Lee, Ph.D. is listed as Chief Scientific Officer Prollenium Medical Technologies, Adjunct Prof, U of Toronto at Class III Sterile Medical Device Biopharm.
AeroLeads has found 1 work email signal at @rutgers.edu for Tim Lee, Ph.D. at Class III Sterile Medical Device Biopharm.
AeroLeads has found 3 phone signal(s) with area code 416, 570 for Tim Lee, Ph.D. at Class III Sterile Medical Device Biopharm.
Tim Lee, Ph.D. is based in Canada, Canada, Canada while working with Class III Sterile Medical Device Biopharm.
Tim Lee, Ph.D. has worked for Class Iii Sterile Medical Device Biopharm, University Of Toronto, Rutgers University, Allergan, and Latham Biopharm Group.
You can use AeroLeads to view verified contact signals for Tim Lee, Ph.D. at Class III Sterile Medical Device Biopharm, including work email, phone, and LinkedIn data when available.
Tim Lee, Ph.D. holds Phd, Biochemical Engineering from Ucl.
Tim Lee, Ph.D. is listed with skills including Six Sigma, Lean Manufacturing, Performance, Cgmp, Gmp, Infectious Diseases, Biotechnology, and Market Research.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contactsCheck these profiles if this is not the Tim Lee, Ph.D. you were looking for.
